On September 3, 2026, DualityBio Ltd. bought 10,000 shares of Duality Biotherapeutics, Inc. - B (09606) at an average of HKD 184.149 per share, involving about HKD 1.84 million.
Prior to the acquisition, DualityBio Ltd.'s long position in Duality Biotherapeutics, Inc. - B was 6.57 million shares, representing 7.19%; following the acquisition, the holding changed to 6.58 million shares, with the long position ratio rising to 7.2%.